A thymic peptide with human clinical research across infectious, immune and oncology contexts; regulatory status varies by country. This record separates established identity and source-linked research context from protocol or commercial fields that are not yet supportable.
FEMETRIC RECORD · PUBLICThymosin Alpha-1
Immune SupportInflammationCellular Repair
Status
Other
Related
3
Sources
1
UPDATED 2026-09-13
01
Protocol references
SOURCE-LINKED
PUBLISHED STUDY
Source-linked research context
No universal administration structure is inferred from the indexed literature. Open the source for the population, intervention and study design.
Route
Subcutaneous
Frequency
See indexed source
Duration
Not indexed
Escalation
Not established
Stage detail pending source extractionStarting and target doses are indexed. Intermediate steps are intentionally not inferred.
PUBLISHED STUDYIntensive Care Medicine, 2013Verified 2026-09-13
Thymosin alpha-1 has been studied as an immune-modulating peptide. Effects and schedules are indication-specific and cannot be condensed into a generic immune-support protocol.
Mechanism summaries are stored with field-level source provenance for editorial audit.
07
Related research goals
08
Related peptides
01PEPTIDE
KPV
A three-amino-acid melanocortin fragment studied in intestinal transport and inflammatory models.
GutBarrier FunctionInflammation
02PEPTIDE
LL-37
An endogenous antimicrobial peptide studied in innate immunity, inflammatory signaling and wound biology.
Immune SupportInflammationWound Repair
03PEPTIDE
Glutathione
A naturally produced antioxidant researched in oxidative stress, redox balance and pigmentation contexts.